1695 related articles for article (PubMed ID: 28939672)
21. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
[TBL] [Abstract][Full Text] [Related]
22. Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study.
Yoon M; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
Thromb Haemost; 2018 Jul; 118(7):1296-1304. PubMed ID: 29723875
[TBL] [Abstract][Full Text] [Related]
23. Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA2DS2-VASc Score of 1 (Men) or 2 (Women)?
Hung Y; Chao TF; Liu CJ; Tuan TC; Lin YJ; Chang SL; Lo LW; Hu YF; Liao JN; Chung FP; Lin WY; Lin WS; Cheng SM; Chen TJ; Lip GY; Chen SA
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27702803
[TBL] [Abstract][Full Text] [Related]
24. Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial fibrillation.
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
J Am Coll Cardiol; 2014 Oct; 64(16):1658-65. PubMed ID: 25323252
[TBL] [Abstract][Full Text] [Related]
25. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
Saliba W; Rennert G
Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
[TBL] [Abstract][Full Text] [Related]
26. Does CHA2DS2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation?
Abraham JM; Larson J; Chung MK; Curtis AB; Lakshminarayan K; Newman JD; Perez M; Rexrode K; Shara NM; Solomon AJ; Stefanick ML; Torner JC; Wilkoff BL; Wassertheil-Smoller S
Am J Med; 2013 Dec; 126(12):1143.e1-8. PubMed ID: 24139523
[TBL] [Abstract][Full Text] [Related]
27. Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.
Fauchier L; Clementy N; Pelade C; Collignon C; Nicolle E; Lip GY
Stroke; 2015 Sep; 46(9):2432-7. PubMed ID: 26251249
[TBL] [Abstract][Full Text] [Related]
28. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.
Komatsu T; Sato Y; Ozawa M; Kunugita F; Yoshizawa R; Morino Y; Nakamura M
Int Heart J; 2014; 55(2):119-25. PubMed ID: 24632957
[TBL] [Abstract][Full Text] [Related]
29. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
[TBL] [Abstract][Full Text] [Related]
30. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
31. Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis.
Senoo K; Lane DA; Lip GY
Int J Cardiol; 2015 Feb; 181():247-54. PubMed ID: 25528530
[TBL] [Abstract][Full Text] [Related]
32. The predictive ability of the CHADS2 and CHA2DS2-VASc scores for bleeding risk in atrial fibrillation: the MAQI(2) experience.
Barnes GD; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Besley D; Krol GD; Froehlich JB; Kaatz S
Thromb Res; 2014 Aug; 134(2):294-9. PubMed ID: 24929840
[TBL] [Abstract][Full Text] [Related]
33. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
[TBL] [Abstract][Full Text] [Related]
34. The CHADS2 and CHA2DS2-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis.
Xiong Q; Chen S; Senoo K; Proietti M; Hong K; Lip GY
Int J Cardiol; 2015 Sep; 195():237-42. PubMed ID: 26048384
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study.
Saliba W; Gronich N; Barnett-Griness O; Rennert G
Am J Med; 2016 Aug; 129(8):843-9. PubMed ID: 27012854
[TBL] [Abstract][Full Text] [Related]
36. CHADS2, CHA2DS2-VASc, ATRIA, and Essen stroke risk scores in stroke with atrial fibrillation: A nationwide multicenter registry study.
Yu I; Song TJ; Kim BJ; Heo SH; Jung JM; Oh KM; Kim CK; Yu S; Park KY; Kim JM; Park JH; Choi JC; Park MS; Kim JT; Hwang YH; Chung JW; Bang OY; Kim GM; Kim YJ; Kim S; Woo SY; Cho H; Seo WK
Medicine (Baltimore); 2021 Jan; 100(3):e24000. PubMed ID: 33545993
[TBL] [Abstract][Full Text] [Related]
37. Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation.
Yao X; Abraham NS; Alexander GC; Crown W; Montori VM; Sangaralingham LR; Gersh BJ; Shah ND; Noseworthy PA
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26908412
[TBL] [Abstract][Full Text] [Related]
38. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
39. Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage.
Chao TF; Liu CJ; Liao JN; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chen TJ; Lip GY; Chen SA
Circulation; 2016 Apr; 133(16):1540-7. PubMed ID: 26969761
[TBL] [Abstract][Full Text] [Related]
40. CHA
Peacock WF; Tamayo S; Patel M; Sicignano N; Hopf KP; Yuan Z
Ann Emerg Med; 2017 May; 69(5):541-550.e1. PubMed ID: 27913059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
